Huaijun Chen

Huaijun Chen

Auto-generated profile, based on publicly available information

Huaijun Chen

Department of Neurosurgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
KLKe Lin
Ke Lin
HCHuaijun Chen
Huaijun Chen
XCXiaojun Chen
Xiaojun Chen
JQJinfu Qian
Jinfu Qian
SHShushi Huang
Shushi Huang
WHWeijian Huang
Weijian Huang
Since the first report in 2005, accumulating interests have been focused on the effect of curcumin in atherosclerosis with discrepancies. Therefore, we conducted a systematic review and meta-analysis to comprehensively estimate its effect against atherosclerosis. Literature search was performed on the database of PubMed, EMBASE, and Cochrane Library to identify relevant studies which estimated the effect of curcumin in atherosclerosis. Reporting effects on aortic lesion area was the primary outcome while effects on serum lipid profiles and circulating inflammatory markers were the secondary outcome. A total of 10 studies including 14 independent pairwise experiments were included in our analysis. We clarified that curcumin could significantly reduce aortic atherosclerotic lesion area (SMD=‐0.89, 95% CI: -1.36 to -0.41, P=0.0003), decrease serum lipid profiles (Tc, MD=‐1.005, 95% CI: -1.885 to -0.124, P=0.025; TG, MD=‐0.045, 95% CI: -0.088 to -0.002, P=0.042; LDL-c, MD=‐0.523, 95% CI: -0.896 to -0.149, P=0.006) as well as plasma inflammatory indicators (TNF-α, MD=‐56.641, 95% CI: -86.848 to -26.433, P<0.001; IL-1β, MD=‐5.089, 95% CI: -8.559 to -1.619, P=0.004). Dose-response meta-analysis predicted effective dosage of curcumin between 0 and 347 mg/kg BW per day, which was safe and nontoxic according to the existing publications. The underlying mechanisms were also discussed and might be associated with the modulation of lipid transport and inflammation in cells within artery walls as well as indirect modulations in other tissues. Clinical evidence from nonatherosclerosis populations revealed that curcumin would lower the lipid profiles and inflammatory responses as it has in a mouse model. However, standard preclinical animal trial designs are still needed; further studies focusing on the optimal dose of curcumin against atherosclerosis and RCTs directly in atherosclerosis patients are also warranted.

26 June 2026 in Cell Death & Disease
Verified
Journal Article
Open access
FZFeicheng Zhou
Feicheng Zhou
HTHaolin Tian
Haolin Tian
HWHaixia Wang
Haixia Wang
HHHongxiang Huang
Hongxiang Huang
XLXuwei Lin
Xuwei Lin
TGTing Gong
Ting Gong
The lung is highly vulnerable to inflammatory injury during sepsis, and acute lung injury (ALI) is a major cause of mortality in critically ill patients. Pyroptosis amplifies immune responses by promoting the release of inflammatory cytokines, and Z-DNA binding protein 1 (ZBP1) has emerged as a key upstream regulator of programmed cell death and inflammatory signaling. Nevertheless, the contribution of ZBP1 to human sepsis-induced ALI and its associated cellular programs remains poorly defined. Here, by integrating single-cell RNA sequencing data from bronchoalveolar lavage fluid (BALF) of patients with sepsis-induced ALI and from septic mouse lungs, we identified a distinct subset of pyroptosis-associated macrophages that expands during disease progression and exhibits ZBP1-dependent inflammasome activation. ZBP1 activation promoted inflammasome assembly, induced macrophage pyroptosis, and released pro-inflammatory mediators that impaired mitochondrial function and barrier integrity of alveolar type II (AT2) epithelial cells. ZBP1 deficiency markedly attenuated macrophage-AT2 inflammatory signaling and reduced the inflammatory amplification loop. Collectively, these findings identify ZBP1-mediated macrophage pyroptosis as a critical mechanism driving epithelial dysfunction during sepsis-induced ALI and provide a rationale for developing ZBP1-targeted strategies to restore immune–epithelial homeostasis and prevent organ failure in sepsis.